Biogen Says Physician Debate About Aduhelm More ‘Pervasive’ Than Anticipated

Lilly Optimistic About Donanemab Opportunity At Citi Event

CEO Michel Vounatsos and US president Alisha Alaimo outlined plans to overcome the Alzheimer’s drug’s launch challenges and hinted at lower sales expectations at a Morgan Stanley investor event.

Conflicting people surrounded by spectators
Biogen is moving forward with publications to reduce doctor debates about Aduhelm • Source: Alamy

More from New Products

More from Scrip